CA2243236A1 - Agents coagulants utiles dans le traitement de la thrombose - Google Patents

Agents coagulants utiles dans le traitement de la thrombose Download PDF

Info

Publication number
CA2243236A1
CA2243236A1 CA 2243236 CA2243236A CA2243236A1 CA 2243236 A1 CA2243236 A1 CA 2243236A1 CA 2243236 CA2243236 CA 2243236 CA 2243236 A CA2243236 A CA 2243236A CA 2243236 A1 CA2243236 A1 CA 2243236A1
Authority
CA
Canada
Prior art keywords
seq
ser
factor
gly
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2243236
Other languages
English (en)
Inventor
Michael Neal Blackburn
William Robert Church
Giora Zeev Feuerstein
Mitchell Stuart Gross
Andrew John Nichols
Eduardo Agustin Padlan
Arunbhai Haribhai Patel
Daniel Robert Sylvester
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Vermont
SmithKline Beecham Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2243236 priority Critical patent/CA2243236A1/fr
Publication of CA2243236A1 publication Critical patent/CA2243236A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention se rapporte à des anticorps monoclonaux dirigés contre des facteurs de coagulation et à leur utilisation dans l'inhibition de la thrombose.
CA 2243236 1996-01-17 1997-01-17 Agents coagulants utiles dans le traitement de la thrombose Abandoned CA2243236A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2243236 CA2243236A1 (fr) 1996-01-17 1997-01-17 Agents coagulants utiles dans le traitement de la thrombose

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/010,108 1996-01-17
US60/029,119 1996-10-24
CA 2243236 CA2243236A1 (fr) 1996-01-17 1997-01-17 Agents coagulants utiles dans le traitement de la thrombose

Publications (1)

Publication Number Publication Date
CA2243236A1 true CA2243236A1 (fr) 1997-07-24

Family

ID=4162666

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2243236 Abandoned CA2243236A1 (fr) 1996-01-17 1997-01-17 Agents coagulants utiles dans le traitement de la thrombose

Country Status (1)

Country Link
CA (1) CA2243236A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116143929A (zh) * 2023-02-03 2023-05-23 北京基科晟斯医药科技有限公司 抗重组人凝血因子VIIa-Fc融合蛋白的抗体及其应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116143929A (zh) * 2023-02-03 2023-05-23 北京基科晟斯医药科技有限公司 抗重组人凝血因子VIIa-Fc融合蛋白的抗体及其应用
CN116143929B (zh) * 2023-02-03 2023-08-01 北京基科晟斯医药科技有限公司 抗重组人凝血因子VIIa-Fc融合蛋白的抗体及其应用

Similar Documents

Publication Publication Date Title
AU706397B2 (en) Anticoagulant agents useful in treatment of thrombosis
EP1282444B1 (fr) Agents antithrombotiques
US20190315886A1 (en) Thrombin antibody, antigen-binding fragment and pharmaceutical use thereof
AU2000278584A1 (en) Antithrombotic agents
US20020136725A1 (en) Antithrombotic agents
US20060057140A1 (en) Anticoagulant agents useful in treatment of thrombosis
US20070190059A1 (en) Antithrombotic agents
CA2243236A1 (fr) Agents coagulants utiles dans le traitement de la thrombose
HK1029513B (en) Anticoagulant humanised antibodies against factor ix, for use in the treatment of thrombosis
HK1107932A (en) Anticoagulant agents useful in treatment of thrombosis
HK1109339A (en) Antithrombotic agents
EP4644426A1 (fr) Anticorps dirigé contre le facteur xi de coagulation et/ou un facteur de forme activé xia de celui-ci et son utilisation

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead